627 filings
ARS
2023 FY
PVCT
Provectus Biopharmaceuticals, Inc.
9 May 24
Annual report to shareholders
10:54am
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
6 May 24
Additional proxy soliciting materials
1:57pm
DEF 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Definitive proxy
6 May 24
1:56pm
8-K
9tft00ly1kx9anlnu
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
8-K
025k6rl4h1zlaq
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
zd9vqj
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
ntgvtnkoln08izjwf
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
d0aikis2q1262d 0j9tv
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
36xvo4w it
22 Jun 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5sml3z2
21 Jun 23
Regulation FD Disclosure
9:50am
DEFA14A
dd0b8 s1yotgav6ris5
21 Jun 23
Additional proxy soliciting materials
9:45am
ARS
1fdxz95ieph2
11 May 23
Annual report to shareholders
3:18pm
DEFA14A
ephu2zz9mh8ym979
1 May 23
Additional proxy soliciting materials
2:01pm